We read with interest the excellent article by Chouela et al1 and the insightful editorial by del Giudice and Marty2 concerning ivermectin therapy for scabies in a recent issue of the ARCHIVES. We would like to offer additional comments concerning dosage, the safety of ivermectin therapy with respect to neurotoxic effects, and concern for developing resistance.
Burkhart CN, Burkhart CG. Ivermectin: A Few Caveats Are Warranted Before Initiating Therapy for Scabies. Arch Dermatol. 1999;135(12):1549-1550. doi:10-1001/pubs.Arch Dermatol.-ISSN-0003-987x-135-12-dlt1299